Omniab, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was License And Milestone Revenue at $9.8 million, 52% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
|---|---|---|---|---|---|---|
| Revenue |
40
|
19
|
26
|
34
|
59
|
—
|
| License And Milestone Revenue |
28
+119.7%
share 68.5%
|
10
-29.5%
share 52.3%
|
14
-33.0%
share 52.5%
|
21
-46.8%
share 60.6%
|
39
share 65.9%
|
—
|
| Services |
10
+27.7%
share 24.0%
|
7
-39.2%
share 38.9%
|
12
-1.9%
share 45.3%
|
12
-35.2%
share 35.7%
|
19
share 31.8%
|
—
|
| Royalty |
1
+284.3%
share 2.7%
|
1
+52.4%
share 4.7%
|
1
-55.2%
share 2.2%
|
1
-6.0%
share 3.8%
|
1
share 2.3%
|
—
|
| X Ploration Revenue |
2
share 4.8%
|
1
share 4.0%
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- OABI (Nasdaq), OABIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1846253
- Former names
- Avista Public Acquisition Corp. II (until Nov 1, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.